CEOI MEMBER SINCE 2020

Kristin Peck is CEO of Zoetis, the world’s leading animal health company, a Fortune 500 organization, with $7.8 billion in annual revenue and 12,100 employees worldwide. She is also a member of the Zoetis board of directors. Before becoming CEO in 2020, Ms. Peck was executive vice president and group president, U.S. operations, business development, and strategy at Zoetis. Named by Barron’s as one of the top CEOs in 2022, and by Fortune as a 2020 Businessperson of the Year, Ms. Peck has been recognized for her leadership and Zoetis’ strong performance in challenging times. Previously, she served as executive vice president, worldwide business development and innovation, at Pfizer Inc., and as a member of Pfizer’s executive leadership team. She held prior roles at Boston Consulting Group (BCG) as well as in private equity and real estate finance at the Prudential Realty Group, the O’Connor Group, and J.P. Morgan. Ms. Peck serves on the boards of BlackRock, Mayo Clinic, and Columbia Business School, and is a member of the Business Roundtable. She is also a board member of Catalyst, a global nonprofit that helps companies accelerate women into leadership. In addition, she is president of HealthforAnimals, the global animal health association, which advocates for the fundamental role of healthy animals in improving global well-being, sustainability, and prosperity.